Research

Research

Research

Drug Screening Core

The Drug Screening Core will build into a high-end biomedical R&D platform aims to explore and deliver innovative treatment measures for major diseases (e.g. cancer and neurodegenerative diseases).

  • This core will comprise two subsidiary platforms:

    This core will comprise two subsidiary platforms:

  • Biomedical discovery subsidiary platform for large biomolecules, such as peptides, proteins, and monoclonal antibodies

    Biomedical discovery subsidiary platform for large biomolecules, such as peptides, proteins, and monoclonal antibodies

  • High-throughput drug screening subsidiary platform

    High-throughput drug screening subsidiary platform